BioSpace News Archive

Drug Development

New Agios Pharmaceuticals Clinical Data From Ongoing Phase 1 Trial Of AG-221 Continue To Show Complete And Durable Remissions In Patients With Difficult To Treat Hematologic Malignancies

June 16, 2014
·
11 min read
Oxford BioMedica PLC Results Of Firm Fundraising And Open Offer

June 16, 2014
·
2 min read
Drug Development

Novo Nordisk A/S Release: Phase 3a Data Showed Liraglutide 3 Mg Demonstrated Significantly Greater Weight Loss Compared To Placebo In Adults With Obesity And Type 2 Diabetes

June 16, 2014
·
10 min read
BGI Raises $320 Million For Diagnostics Division

June 16, 2014
·
1 min read
Drug Development

Astex Pharmaceuticals Presents Final Results Of Phase 2 Study Of SGI-110 In Treatment Naïve Elderly Acute Myeloid Leukemia At The European Hematology Association Meeting

June 16, 2014
·
1 min read
Drug Development

Islet Sciences Presents Positive Clinical Results For Best-In-Class SGLT2 Inhibitor At American Diabetes Association Annual Meeting

June 16, 2014
·
6 min read
Biotech Bay

Zosano Pharma, Inc. To Present At The 74th American Diabetes Association Scientific Session

June 16, 2014
·
1 min read
Business

Actinium Pharmaceuticals, Inc. Engages A Leading CRO To Support Phase 3 Trial Of Iomab-B

June 16, 2014
·
1 min read
Drug Development

Studies Show Investigational New Insulin Glargine Product From Eli Lilly and Company And Boehringer Ingelheim Corporation Similar Safety And Efficacy Profile To Lantus®

June 16, 2014
·
13 min read
Business

Neogen Corporation Licenses Innovative SenesTech Rodent Control Technology

June 16, 2014
·
2 min read